The Japan Diabetes Society (JDS) decided to use National Glycohemoglobin Standardization Program (NGSP) values, as well as JDS HbA~1c~ values, in clinical practice for international clinical harmonization of HbA~1c~ \[[@B1]\]. Accordingly, NGSP certification of Japanese manufacturers of diagnostic reagents and instruments related to HbA~1c~ was initiated in February, 2012, through NGSP Network Laboratory, the Asian Secondary Reference Laboratory (ASRL) \#1 \[[@B2]\]. As a result, 21 routine methods were certified in 2012 and 42 in 2013. Moreover, traceability to the NGSP reference system can now be endorsed by both manufacturer certification and the College of American Pathologists (CAP) survey. The CAP survey is useful for monitoring between-certification proficiency of certified methods. However, only a few manufacturers participate in the CAP survey in Japan. Thus, proficiency testing (PT) similar to the CAP survey targeting NGSP-certified manufacturers and laboratories in Asia has been proposed and executed by ASRL \#1 in collaboration with the Japan Reference Measurement Institute (JRMI). The committee for the PT was organized by the Reference Material Institute for Clinical Chemistry Standards (ReCCS) in collaboration with JRMI.

Five PT samples were prepared: PT samples 1, 2, 4, and 5 were single-donor whole-blood aliquots, and PT sample 3 was a mixture of PT samples 1 and 4, with plasma replaced by physiological saline solution. PT samples were drawn from two Japanese individuals in Japan and two diabetes patients in USA with informed consent and with the approval of the Ethics Committee of ReCCS. PT sample 3 for A~1c~ GEAR in [Table 1](#T1){ref-type="table"} shows abnormally high HbA~1c~ values because only whole blood can be applied to A~1c~ GEAR; therefore, in the mean value obtained by immunoassay, the A~1c~ GEAR result of this sample was excluded in [Table 2](#T2){ref-type="table"}.

ReCCS prepared and shipped the test samples. PT samples were stored in a refrigerator (2-8℃) until shipment, and at each laboratory, they were removed from the container immediately on receipt and then stored in a refrigerator (2-8℃) until use. Analyses were completed within two days of receipt when less than 14 days passed after each sample collection.

The participated measurement systems were NGSP certified (according to manufacturer\'s methods and laboratory certification) by ASRL \#1, SRL \#8, and SRL \#9. Each PT sample was measured in duplicate. Measured HbA~1c~ values were reported to 2 decimal places. Mean values (calculated to 3 decimal places) of the duplicate values for each PT sample were reported as final values, which were compared with target values determined by ASRL \#1. The obtained values were consistent with those of SRL \#8 and SRL \#9. An overall test of coincidence by 2 least squares linear regression lines was performed using Microsoft Office Excel 2007.

A total of 33 laboratories (29 Japanese and four overseas laboratories) participated in the PT. Among these facilities, 22 were certified by NGSP through ASRL \#1, two through SRL \#8, and nine through SRL \#9. Furthermore, 17 participating laboratories used immunoassay, four used enzymatic assay, and 12 used HPLC. PT samples 4 and 5 yielded HbA~1c~ values over 12 NGSP%, which exceeded measurement ranges for some measurement instruments; therefore, these values were excluded for those systems. Target values of PT samples 1, 2, 3, 4, and 5 were determined by ASRL \#1 to be 4.86 NGSP%, 5.64 NGSP%, 8.00 NGSP%, 12.68 NGSP%, and 12.78 NGSP%, respectively. The comparison of values as measured by instruments and the NGSP/ASRL target values are shown in [Table1](#T1){ref-type="table"}.

The regression line comparing the relationship between total mean values and target values was Y (the total mean values) = 1.013×(the target value)+0.141. That is, the total mean values were higher than the target values. Furthermore, the values of CV of PT samples 1 through 5 were 3.72%, 2.54%, 2.23%, 2.41%, and 2.71%, respectively. PT sample 3 (containing red cells and saline) did not show any difference compared with other hemolyzed blood samples. CV values were 2.51-4.51% by immunoassay, 1.05-2.53% by enzymatic assay, and 1.73-2.63% by HPLC ([Table 2](#T2){ref-type="table"}).

Compatibility with JDS criteria (less than or equal to a relative bias of ±5.0% by mean of duplicate measurement) was checked by comparing the measured values of test samples 1 through 3 for the certification of 5% to10.0% HbA~1c~. The results indicate that 26 out of 28 methods in test sample 1, 26 out of 28 in test sample 2, and 26 out of 27 in test sample 3 were compatible with JDS criteria \[[@B1]\]. [Fig. 1](#F1){ref-type="fig"} shows combination plots of bias data in this study and bias data from NGSP certification through ASRL \#1 conducted during March and May, 2012. Bias plots of mean values versus target values of PT samples in this report are also shown for comparison, and they are in good agreement with each other.

The determined target values using the Central Primary Reference Laboratory reference panels (100 samples) correspond with measured values obtained by SRL \#3 and SRL \#9. In conclusion, the PT is useful to monitor NGSP-certified methods. Mean values at each level correspond well with the target value, including point-of-care testing.

We are grateful to Dr. R. Little, University of Missouri School of Medicine, for giving us the data of NGSP network Laboratory Monitoring for the measurement of HbA~1c~ PT samples by the NGSP Laboratory Network.

**Authors\' Disclosures of Potential Conflicts of Interest:** No potential conflicts of interests relevant to this article were reported.

![Observed HbA~1c~ values of each participating laboratory compared to the NGSP/ASRL target (dashed line) in 2012 based on ASRL PT data. Closed circles show within ±5% (dotted line) of relative bias. Open circles show within ±7% (dashed line) of relative bias. Open squares show biases of all manufacturers versus ASRL target PT samples.\
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###### Participating laboratories and supplemental data HbA1c unit : NGSP%
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  Method              Participating laboratory                                                Measurement system                                  PT sample                                 
  ------------------- ----------------------------------------------------------------------- --------------------------------------------------- ----------- ------- ---------- ---------- ----------
  Immunoassay         Kyowa Medex Co., Ltd.                                                   Determiner HbA1c/DM-JACK                            4.755       5.485   7.895      12.530     12.560
  Immunoassay         Kyowa Medex Co., Ltd.                                                   Determiner HbA1c/JCA-BM9130                         4.805       5.500   7.940      12.565     12.625
  Immunoassay         Kyowa Medex Co., Ltd.                                                   Determiner L HbA1c/DM-JACK                          4.795       5.520   8.005      12.540     12.625
  Immunoassay         Kyowa Medex Co., Ltd.                                                   Determiner L HbA1/JCA-BM9130                        4.795       5.480   7.985      12.485     12.570
  Immunoassay         TFB, INC.                                                               Rapidia Auto HbA1c-L/Hitachi 7170s                  4.570       5.400   7.660      12.200     12.420
  Immunoassay         ROHM Co., Ltd.                                                          Banalyst Ace HbA1c/Banalyst Ace                     4.700       5.500   7.900      High^\*^   High^\*^
  Immunoassay         ROHM Co., Ltd.                                                          Spotchem Banalyst HbA1c/Spotchem Banalyst SI-3610   4.800       5.600   8.000      High^\*^   High^\*^
  Immunoassay         Wako Pure Chemical Industries, Ltd.                                     Autokit HbA1c/Hitachi 7170S                         4.790       5.440   8.075      12.585     12.535
  Immunoassay         SAKAE Corporation                                                       A1c GEAR                                            4.650       5.300   8.650^†^   12.050     12.500
  Immunoassay         Kotobiken Medical Laboratories, Inc. Biken Central Laboratory Tsukuba   Determiner L HbA1c/JCA-BM9130                       4.830       5.360   7.660      12.205     11.965
  Immunoassay         Siemens Healthcare Diagnostics                                          DCA2000+ / DCA Vantage                              4.950       5.600   8.150      13.050     13.300
  Immunoassay         Siemens Healthcare Diagnostics                                          Dimension RxL MAX                                   5.400       6.065   8.440      13.190     13.180
  Immunoassay         Ortho Clinical Diagnostics                                              Vitros d%A1c/Vitros 5,1FS                           4.970       5.475   8.125      12.735     12.780
  Immunoassay         Ortho Clinical Diagnostics                                              Vitros d%A1c/Vitros 5600                            4.980       5.475   8.110      12.605     12.585
  Immunoassay         Roche Diagnostics                                                       TQ HbA1c Gen.3/cobas c501                           4.650       5.475   8.275      12.495     12.590
  Immunoassay         Roche Diagnostics                                                       TQ HbA1c Gen.2/cobas c501                           5.095       5.645   8.135      12.280     12.335
  Immunoassay         Boditech Med. Inc                                                       i-ChromaTM                                          4.450       5.600   8.050      12.150     12.450
  Enzymatic assay     Kyowa Medex Co., Ltd.                                                   MetaboLead HbA1c/JCA-BM9130                         4.850       5.440   7.910      12.880     13.065
  Enzymatic assay     SEKISUI MEDICAL CO., LTD.                                               Norudia N HbA1c/Hitachi 7170S                       4.855       5.715   7.690      12.730     13.420
  Enzymatic assay     Hitachi Chemical Co., Ltd.                                              Seratestum A1C                                      4.780       5.465   8.085      12.555     12.855
  Enzymatic assay     NIHON KOHDEN CORPORATION                                                BM Test HbA1c/JCA-BM6010                            4.870       5.445   8.140      13.205     13.315
  Ion-exchange HPLC   Kotobiken Medical Laboratories, Inc. Niigata Laboratory                 HLC-723 G8                                          4.740       5.460   7.920      12.690     12.840
  Ion-exchange HPLC   SRL, Inc.                                                               ADAMS A1c HA-8160                                   4.900       5.650   8.200      12.800     13.100
  Ion-exchange HPLC   Bio-Rad Laboratories                                                    Variant II Turbo                                    4.635       5.535   7.875      12.530     12.675
  Ion-exchange HPLC   Bio-Rad Laboratories                                                    D-10                                                4.800       5.600   7.950      12.500     12.600
  Ion-exchange HPLC   Tosoh Corporation                                                       HLC-723 G7                                          4.710       5.510   7.975      12.735     12.885
  Ion-exchange HPLC   Tosoh Corporation                                                       HLC-723 G8                                          4.680       5.500   7.965      12.805     12.865
  Ion-exchange HPLC   Tosoh Corporation                                                       HLC-723 G9                                          4.700       5.525   7.995      12.855     12.910
  Ion-exchange HPLC   Tosoh Corporation                                                       HLC-723 GX                                          4.695       5.495   7.980      12.835     12.890
  Ion-exchange HPLC   Korea Association of Health Promotion                                   HLC-723 G8                                          4.740       5.585   8.100      13.035     13.120
  Ion-exchange HPLC   Seoul National University Bundang Hospital                              Variant II Turbo                                    4.600       5.600   8.050      13.100     13.400
  Ion-exchange HPLC   NEODIN MEDICAL INSTITUTE                                                HLC-723 G8                                          4.900       5.750   8.250      13.150     13.250
  Ion-exchange HPLC   Chung-Ang University Hospital                                           Variant II Turbo                                    4.450       5.300   7.650      12.500     12.600

^\*^out of measurement range; ^†^abnormally high values (whole blood only can be applied) for sample 3 (mixture of samples 1 and 4, replacing the plasma with physiological saline solution).

Abbreviations: NGSP, National Glycohemoglobin Standardization Program; PT, proficiency testing; ASRL, Asian Secondary Reference Laboratory; ReCCS, Reference Material Institure for Clinical Chemistry Standards.

###### Comparison of three methods: immunoassay, enzymatic assay, and HPLC HbA~1c~ unit: NGSP% for target value, Mean and SD
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  Sample         1                                         2       3       4        5
  -------------- ----------------------------------------- ------- ------- -------- --------
  Target value   4.863                                     5.643   7.997   12.678   12.779
  Method         Immunoassay (17 measurement systems)                               
  Mean           4.823                                     5.525   8.025   12.511   12.601
  SD             0.217                                     0.165   0.199   0.317    0.317
  CV (%)         4.51                                      2.99    2.47    2.53     2.51
  Method         Enzymatic assay (4 measurement systems)                            
  Mean           4.855                                     5.552   7.997   12.843   13.164
  SD             0.051                                     0.140   0.198   0.239    0.220
  CV (%)         1.05                                      2.53    2.48    1.86     1.67
  Method         HPLC (12 measurement systems)                                      
  Mean           4.713                                     5.543   7.993   12.795   12.928
  SD             0.124                                     0.110   0.155   0.222    0.250
  CV (%)         2.63                                      1.99    1.94    1.73     1.93

Abbreviations: NGSP, National Glycohemoglobin Standardization Program.
